Georgia Tech Research Corporation
Atlanta, Georgia, United States
Purpose
to demonstrate the feasibility and efficacy of inhalation powder lung delivery of synthetic mRNA encoding broadly neutralizing antibodies against influenza infections in a rodent model
Division
Global Health
Date
June 2018
Region Served
GLOBAL
Committed amount
$433,275
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
15
Grantee location
Atlanta, Georgia, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.